ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

EVG Evgen Pharma Plc

0.80
0.00 (0.00%)
20 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma Plc LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 422k -4.04M -0.0147 -0.51 2.06M
Evgen Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker EVG. The last closing price for Evgen Pharma was 0.80p. Over the last year, Evgen Pharma shares have traded in a share price range of 0.75p to 3.95p.

Evgen Pharma currently has 274,888,117 shares in issue. The market capitalisation of Evgen Pharma is £2.06 million. Evgen Pharma has a price to earnings ratio (PE ratio) of -0.51.

Evgen Pharma Share Discussion Threads

Showing 6226 to 6249 of 13025 messages
Chat Pages: Latest  257  256  255  254  253  252  251  250  249  248  247  246  Older
DateSubjectAuthorDiscuss
23/12/2020
13:26
Looking nice for Christmas and beyond....;-)))
moneymunch
23/12/2020
13:15
ooh eerr, thanx guys, lookin much better here now :-) Cheers Wan :-)
wanobi
23/12/2020
13:08
Takes all sorts Bumpa, even the sad little scrote troll type... ha ha ha .....in the meantime , news on the first 100 patients recruited and assessed in the Covid trial could be close, as well as disclosure of the solid tumour callaborator and multiple potential news on the rest of the pipeline.....a potential stellar year ahead for little old EVG and its shareholders with any luck...Gl ;-)
moneymunch
23/12/2020
12:33
mm - pointless 🤷‍a94;️
bumpa33
23/12/2020
12:10
Lol Bumpa, what a life the sad little blue so and so must live...Ho Ho Ho ;-)))
moneymunch
23/12/2020
12:04
Literally nothing available anywhere @ 11.
bumpa33
23/12/2020
11:51
The phantom red ticker of old London Town is busy I see...
bumpa33
23/12/2020
11:46
Sooner or later this is going to pop!!! ;-)
moneymunch
23/12/2020
09:56
and a 250k delayed trade from 9.23am which certainly looks like a buy. ;-)
moneymunch
23/12/2020
09:47
Wow...maybe the same buyer who had the 3 x 300k's on Monday???? hopefully someone in the know....Gl ;-)
moneymunch
23/12/2020
09:44
And another :)
on target
23/12/2020
09:41
A nice 335k buy just in....the smart money is accumulating by the looks of it....Gla ;-)
moneymunch
23/12/2020
08:45
More compelling research on the panacea potential of Sulforaphane. Gla ;-)

Research

Reductive stress in neuroblastoma cells aggregates protein and impairs neurogenesis

December 07, 2020

In the current study, the researchers used sulforaphane to establish RS in proliferating and differentiating Neuro 2a neuroblastoma cells grown in culture. Sulforaphane activates Nrf2/ARE signaling, leading to antioxidant augmentation. Specifically, they found that sulforaphane-mediated Nrf2 activation diminished reactive oxygen species in a dose-dependent manner leading to RS. The resulting RS abrogated oxidant signaling and impaired endoplasmic reticulum function, which promoted protein aggregation and proteotoxicity, and impaired neurogenesis. This included elevated Tau and α-synuclein and their co-localization with other protein aggregates in the cells.

Namakkal-Soorappan says they were also surprised to see that acute RS impaired neurogenesis, as measured by reduced neurite outgrowth and length, and that maintaining the cells in sustained RS conditions for five consecutive generations dramatically reduced differentiation and prevented the formation of axons.

This impairment of neurogenesis occurs through activation of the pathogenic GSK3β/Tau cascade to promote phosphorylation of Tau and create proteotoxicity.

Intriguingly, there have been reports of increased levels of enzymes that can promote RS, both in the brains of Alzheimer’s patients and in the post-mortem brains of Alzheimer’s and Parkinson’s patients. Also, attempts to promote neurogenesis in neurodegenerative diseases using small molecule antioxidants have had poor outcomes.

stress.3Rajasekaran Namakkal-Soorappan, Ph.D.“Therefore, clinical evidence warrants a closer investigation and further understanding of redox changes and their impact at the onset and progression of neurodegeneration,” Namakkal-Soorappan said.

moneymunch
22/12/2020
16:37
Perfectly poised for news....Gla ;-)
moneymunch
22/12/2020
14:02
Yes, that comment by Huw was very interestng. To be frank i am surprised that he said what he did, but he is no fool and he must be fairly certain of the facts to say what he did.
mesquida
22/12/2020
13:43
mesquida - looking strong and nice to see some good momentum behind it. Any pull back should be limited to the 200 dma currently 10.21p. That non public preclinical news regarding tumors that the CEO eluded to the other week has got me interest.
kingalf
22/12/2020
13:07
Sorry peanut, i'm only joking mate, but half hoping/expecting Piers to comment along those lines, if indeed SFX-01 was proven to be a therapuetic benefit for ARDS/pnuemonia Covid-19 and no doubt the share price would be sailing past £1 and more .....and potentially we could find out very soon, just as soon as the first 100 patients are recruited and assessed. Gl ;-)

ps the pick up in volume suggests that some sort of news from Evgen's multiple pipeline could be coming. ;-)

moneymunch
22/12/2020
13:07
Well, kingalf, it does really now look like a decisive break above the 200 day moving average, do you agree ?
mesquida
22/12/2020
12:59
When was this MM?
peanut100
22/12/2020
12:02
absolutely zilch to buy
yus777
22/12/2020
11:39
nt trade only hmm
yus777
22/12/2020
11:24
Piers Morgan on Good Morning Britain, interviewing a member of the public..."let's get this straight, your 90 year old Granny was on deaths door with ARDS/ pneumonia and Covid-19 and she was given a course of pills derived from Broccoli and she's now made a full recovery and planning to do the London Marathon...whatever next...well you heard it here first viewers...SFX-01...the wonder drug"....:-)))
moneymunch
22/12/2020
11:17
total of 400k plus bought at 11p load up gents
yus777
22/12/2020
11:01
Every chance of a commercial JV in the pipeline and every chance of a sudden and significant re-rate to reflect fair value on Evgen's undoubted transformational potential. Gla ...On and UP!!! ;-)
moneymunch
Chat Pages: Latest  257  256  255  254  253  252  251  250  249  248  247  246  Older

Your Recent History

Delayed Upgrade Clock